NextCure, Inc.
🏢 View company profile →3Patents
3Active
3Granted
40Portfolio score
Filing activity: Aug 3, 2017 → Jan 23, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12286478B2 | B7-H4 antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US12084495B2 | Compositions and methods for modulating LAIR signal transduction | Chemistry; Metallurgy | 0 | Active |
| US11390675B2 | Antibodies for Siglec-15 and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.